Per-SVR research study aims to help curb hep C reinfection

The new wave is here. Now that effective hepatitis C treatments are available, there is a global movement to end hepatitis C with surging political will.

It is a United Nations Sustainable Development Goal to save 10 million lives by 2030 through effective hepatitis C treatment. The BC Government, in March 2018, made treatment accessible to any British Columbian living with chronic hepatitis C.

Now, we need your help. The BC-CfE’s Viral Hepatitis Research Program aims to monitor and evaluate the hepatitis C epidemic in BC. We have made huge advances against HIV. By expanding access to knowledge through research and to treatment through Treatment as Prevention¨, we can now apply these strategies to ending another public health threat through Targeted Disease Elimination. Focusing largely on the intersections between hepatitis C, HIV and harm reduction, the BC-CfE is developing evidence-based research to inform health policy.

Through the BC-CfE’s Per-SVR Study (pronounced “Persevere!”), we are aiming to better understand if, how and when hepatitis C reinfection may occur – especially among marginalized populations such as individuals who inject drugs, men who have sex with men and people involved in sex work. Per-SVR is recruiting participants in a multi-year study to learn more about the experiences of people who have been treated with the new “DAA” or direct acting antiretroviral hepatitis C medications.

Physicians and other health care providers can help move British Columbia towards the goal of Targeted Disease Elimination¨ of hepatitis C.Share the word about Per-SVR by displaying a poster, sharing a postcard and talking about it. By introducing patients to treatment and to the study, you will contribute to advancing research and eliminating a public health threat.

Reach out to Caroline Dobuzinskis at cdobuzin@bccfe.ca for more information and promotional materials.

Watch the video below to learn more about Per-SVR and how it is moving to address the spread of hepatitis C.

Share the Post:
Scroll to Top

During the Canada Post strike, the following measures have been undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office.  (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During this time, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service.